About GE Healthcare
As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices,data analytics, applications and services, supported by its Edison intelligence platform.
With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health,digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world. We embrace a culture of respect, transparency, integrity and diversity.
SonazoidTM(perfluorobutane microbubbles, GE Healthcare, Oslo, Norway) is a ultrasound contrast agent approved for use in ultrasound imaging of focal liver lesions, consisting of microbubbles with increased stability under ultrasound fields, which enables continuous diagnostic scanning with an excellent contrast effect.